Advertisement

Introduction to the B-Cell Lymphomas

  • Amrita Goyal
  • Aliyah R. Sohani
  • Alexandra E. Kovach
  • Joi B. Carter
  • Jeffrey A. Barnes
  • Lyn McDivitt DuncanEmail author

Abstract

The human body contains a vast array of B cells, with phenotypes ranging from the naïve B cell to the centrocyte, centroblast, immunoblast, plasmablast, and plasma cell. Each of these B-cell subsets has different functional, proliferative, and migratory capacities, and the diversity of cutaneous B-cell lymphoma (CBCL) reflects the variety of non-neoplastic B-cell counterparts. The WHO-EORTC classification [1] recognizes four cutaneous B-cell lymphomas: primary cutaneous marginal zone lymphoma (pcMZL or MALT lymphoma), primary cutaneous follicle-center lymphoma (pcFCL), primary cutaneous diffuse large B-cell lymphoma, leg-type (pcDLBCL), and intravascular large B-cell lymphoma (ivLBCL). Here we offer a schema for understanding and distinguishing these lymphomas. Each lymphoma is addressed individually in subsequent chapters.

Keywords

B-cell Centrocyte Centroblast Immunoblast Plasmablast Plasma cell Primary cutaneous follicle center b-cell lymphoma Primary cutaneous marginal zone B-cell lymphoma Intravascular large B-cell lymphoma pcFCL pcMZL IVLBCL Diffuse large B-cell lymphoma pcDLBCL Follicle center cell Follicular dendritic cell Marginal zone cell BCL2 BCL6 CD10 MUM1] 

References

  1. 1.
    Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.PubMedCrossRefGoogle Scholar
  2. 2.
    Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin Dermatol. 2010;28:568–74.PubMedCrossRefGoogle Scholar
  3. 3.
    Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol. 2007;25:1581–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112:1600–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008.Google Scholar
  6. 6.
    Fernandez-Flores A. Current concepts on cutaneous MALT lymphomas. Am J Dermatopathol. 2013;35:477–84.PubMedCrossRefGoogle Scholar
  7. 7.
    Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38:877–98.PubMedCrossRefGoogle Scholar
  8. 8.
    Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Hauser A, Kerfoot S, Haberman A. Cellular choreography in the germinal center: new visions from in vivo imaging. Semin Immunopathol. 2010;32:239–55.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8:22–33.PubMedCrossRefGoogle Scholar
  11. 11.
    Gatto D, Brink R. The germinal center reaction. J Allergy Clin Immunol. 2010;126:898–907; quiz 908–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Victora GD, Schwickert TA, Fooksman DR, Kamphorst AO, Meyer-Hermann M, Dustin ML, et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell. 2010;143:592–605.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Bannard O, Horton RM, Allen CDC, An J, Nagasawa T, Cyster JG. Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection. Immunity. 2013;39:912–24.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Nakayama Y, Stabach P, Maher SE, Mahajan MC, Masiar P, Liao C, et al. A limited number of genes are involved in the differentiation of germinal center B cells. J Cell Biochem. 2006;99:1308–25.PubMedCrossRefGoogle Scholar
  15. 15.
    Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J, Miljkovic V, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100:2639–44.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.PubMedCrossRefGoogle Scholar
  17. 17.
    Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.PubMedCrossRefGoogle Scholar
  18. 18.
    Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, Greally J, et al. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol. 2007;8:705–14.PubMedCrossRefGoogle Scholar
  19. 19.
    de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM. Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in diagnosis and classification. Am J Surg Pathol. 2001;25:732–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Amrita Goyal
    • 1
  • Aliyah R. Sohani
    • 2
  • Alexandra E. Kovach
    • 3
  • Joi B. Carter
    • 4
  • Jeffrey A. Barnes
    • 5
  • Lyn McDivitt Duncan
    • 6
    Email author
  1. 1.Harvard-MIT Division of Health Sciences and TechnologyHarvard Medical SchoolBostonUSA
  2. 2.Hematopathology Service, Department of PathologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Department of PathologyBoston Children’s HospitalBostonUSA
  4. 4.Department of DermatologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  5. 5.Comprehensive Cutaneous Lymphoma Program, Department of MedicineMassachusetts General Hospital Cancer CenterBostonUSA
  6. 6.Dermatopathology Service, Department of PathologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations